Cancer Research SABCS  Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Frankel, A.
Right arrow Articles by Kerbel, R. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frankel, A.
Right arrow Articles by Kerbel, R. S.
[Cancer Research 61, 4837-4841, June 15, 2001]
© 2001 American Association for Cancer Research


Molecular Biology and Genetics

Induction of Anoikis and Suppression of Human Ovarian Tumor Growth in Vivo by Down-Regulation of Bcl-XL1

Andrea Frankel, Kirill Rosen, Jorge Filmus and Robert S. Kerbel2

Molecular and Cellular Biology Research, Sunnybrook and Women’s College Health Sciences Centre and Departments of Laboratory Medicine and Pathobiology and Medical Biophysics, University of Toronto, Toronto, Ontario, M4N 3M5 Canada

Normal or immortal epithelial cells are sensitive to a form of apoptosis, commonly referred to as anoikis, which is induced by detachment from the extracellular matrix (ECM). In contrast, development of carcinomas is associated with acquisition of cellular resistance to anoikis. However, whether human cancer cells deprived of anoikis resistance necessarily display reduced tumorigenic properties in vivo is unknown. We decided to address this question using human ovarian carcinoma cells as a model. Bcl-XL, an apoptotic factor considered to play an important role in (resistance to) anoikis, is overexpressed in ovarian cancer, and represents an unfavorable prognostic indicator for this type of human malignancy. We therefore evaluated whether Bcl-XL can be used as a tool to manipulate anoikis resistance and tumorigenicity of ovarian cancer cells. We show here that when nonmalignant ovarian epithelial cells are detached from the ECM, down-regulation of Bcl-XL and apoptotic cell death are observed, although these events do not occur in ovarian carcinoma cells. Moreover, enforced down-regulation of Bcl-XL by transfection with antisense cDNA in the anoikis-resistant and highly tumorigenic HEY ovarian carcinoma cell line had no impact on the viability of these cells under adherent conditions but caused significant apoptosis in response to detachment from the ECM. This change was associated with a strong inhibition of tumorigenicity of the Bcl-XL-deficient HEY cells in nude mice, both s.c. and in the peritoneal cavity. These results suggest a critical role for Bcl-XL in the maintenance of anoikis resistance in ovarian cancer cells. They also serve to establish a functional linkage between this property and the ability of human cancer cells to grow aggressively in vivo. Consequently, targeting molecular mechanisms responsible for anoikis resistance may serve as a potentially effective therapeutic strategy for the treatment of such human malignancies as ovarian cancer.




This article has been cited by other articles:


Home page
Cancer Res.Home page
N. M. Moss, M. V. Barbolina, Y. Liu, L. Sun, H. G. Munshi, and M. S. Stack
Ovarian Cancer Cell Detachment and Multicellular Aggregate Formation Are Regulated by Membrane Type 1 Matrix Metalloproteinase: A Potential Role in I.p. Metastatic Dissemination
Cancer Res., September 1, 2009; 69(17): 7121 - 7129.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
C.-H. Chou, L.-H. Wei, M.-L. Kuo, Y.-J. Huang, K.-P. Lai, C.-A. Chen, and C.-Y. Hsieh
Up-regulation of interleukin-6 in human ovarian cancer cell via a Gi/PI3K-Akt/NF-{kappa}B pathway by lysophosphatidic acid, an ovarian cancer-activating factor
Carcinogenesis, January 1, 2005; 26(1): 45 - 52.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
W. D Stein, T. Litman, T. Fojo, and S. E Bates
A Serial Analysis of Gene Expression (SAGE) Database Analysis of Chemosensitivity: Comparing Solid Tumors with Cell Lines and Comparing Solid Tumors from Different Tissue Origins
Cancer Res., April 15, 2004; 64(8): 2805 - 2816.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Kari, T. O. Chan, M. Rocha de Quadros, and U. Rodeck
Targeting the Epidermal Growth Factor Receptor in Cancer: Apoptosis Takes Center Stage
Cancer Res., January 1, 2003; 63(1): 1 - 5.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Rosen, W. Shi, B. Calabretta, and J. Filmus
Cell Detachment Triggers p38 Mitogen-activated Protein Kinase-dependent Overexpression of Fas Ligand. A NOVEL MECHANISM OF ANOIKIS OF INTESTINAL EPITHELIAL CELLS
J. Biol. Chem., November 22, 2002; 277(48): 46123 - 46130.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Rosen, M. L. Coll, A. Li, and J. Filmus
Transforming Growth Factor-alpha Prevents Detachment-induced Inhibition of c-Src Kinase Activity, Bcl-XL Down-regulation, and Apoptosis of Intestinal Epithelial Cells
J. Biol. Chem., September 28, 2001; 276(40): 37273 - 37279.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.